行情

CDMO

CDMO

Avid Bioservices
NASDAQ

实时行情|Nasdaq Last Sale

5.23
-0.01
-0.19%
盘后: 5.23 0 0.00% 16:00 11/15 EST
开盘
5.29
昨收
5.24
最高
5.40
最低
5.20
成交量
18.25万
成交额
--
52周最高
7.15
52周最低
3.370
市值
2.94亿
市盈率(TTM)
-25.9553
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

CDMO 新闻

  • 分析师:某位投资大佬可能正在“嗅探”Netflix
  • 新浪财经.1小时前
  • FAA局长:737 MAX机型获复飞批准"不受时间表指引"
  • 新浪美股.1小时前
  • ExodusPoint对冲基金将重新开放 拟募集超过20亿美元
  • 新浪美股.2小时前
  • 愿景基金二期已筹集20亿美元 但尚不及目标资金零头
  • 新浪美股.2小时前

更多

所属板块

制药
+1.25%
制药与医学研究
+1.29%

热门股票

名称
价格
涨跌幅

CDMO 简况

Avid Bioservices, Inc., formerly Peregrine Pharmaceuticals, Inc., is a biopharmaceutical company. The Company is engaged in providing contract manufacturing services for third party customers on a fee-for-service basis while also supporting its internal drug development efforts. The Company delivers pharmaceutical products through its contract manufacturing business and through licensing its development-stage immunotherapy products. The company provides a comprehensive range of process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. Its services include cGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The Company also provides a variety of process development activities, including cell line development and optimization.
展开

Webull提供Avid Bioservices Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。